OBJECTIVES: To determine granulocyte colony-stimulating factor (G-CSF), epithelial neutrophil-activating peptide (ENA)-78, and interleukin (IL)-8 in BAL fluid (BALF), epithelial lining fluid (ELF), and serum for establishing the concentration gradient of G-CSF, ENA-78, and IL-8 between the blood and the alveolar space in ARDS and acute lung injury (ALI); and to evaluate the relationship of G-CSF, IL-8, and ENA-78 to pulmonary neutrophilia and severity of lung injury. DESIGN: Prospective study. SETTING: An adult trauma/surgical ICU. PATIENTS: Nineteen patients with ARDS and 10 patients with ALI. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: BAL and blood sampling simultaneously within 12 h and 24 h after onset of ARDS/ALI; G-CSF was detected in BALF in 18 of 19 patients with ARDS, in 7 of 10 patients with ALI, and in all serum samples. G-CSF in BALF and serum was significantly higher in ARDS than in ALI. ENA-78 was detected in BALF in 14 of 19 patients with ARDS, in 8 of 10 patients with ALI, and in serum of all patients. Levels in BALF and serum were not different between ARDS and ALI. IL-8 was detected in all patients; concentrations in BALF in ARDS were significantly higher than in ALI. Concentrations of G-CSF, ENA-78, and IL-8 in ELF were significantly higher than in serum. G-CSF in BALF and serum and IL-8 in BALF correlated positively with pulmonary neutrophilia. G-CSF in serum and IL-8 in BALF correlated negatively with PaO(2)/fraction of inspired oxygen (FIO(2)) ratio. However, ENA-78 did not show a correlation with neutrophil count or with PaO(2)/FIO(2) ratio. CONCLUSIONS: G-CSF may be pathophysiologically important for accumulation and activation of neutrophils in ARDS. Local G-CSF production is the likely driving force for neutrophils rather than elevation of circulating levels. In comparison to ENA-78, IL-8 seems to be the predominant neutrophil chemoattractant in the early phase of ARDS.
OBJECTIVES: To determine granulocyte colony-stimulating factor (G-CSF), epithelial neutrophil-activating peptide (ENA)-78, and interleukin (IL)-8 in BAL fluid (BALF), epithelial lining fluid (ELF), and serum for establishing the concentration gradient of G-CSF, ENA-78, and IL-8 between the blood and the alveolar space in ARDS and acute lung injury (ALI); and to evaluate the relationship of G-CSF, IL-8, and ENA-78 to pulmonary neutrophilia and severity of lung injury. DESIGN: Prospective study. SETTING: An adult trauma/surgical ICU. PATIENTS: Nineteen patients with ARDS and 10 patients with ALI. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: BAL and blood sampling simultaneously within 12 h and 24 h after onset of ARDS/ALI; G-CSF was detected in BALF in 18 of 19 patients with ARDS, in 7 of 10 patients with ALI, and in all serum samples. G-CSF in BALF and serum was significantly higher in ARDS than in ALI. ENA-78 was detected in BALF in 14 of 19 patients with ARDS, in 8 of 10 patients with ALI, and in serum of all patients. Levels in BALF and serum were not different between ARDS and ALI. IL-8 was detected in all patients; concentrations in BALF in ARDS were significantly higher than in ALI. Concentrations of G-CSF, ENA-78, and IL-8 in ELF were significantly higher than in serum. G-CSF in BALF and serum and IL-8 in BALF correlated positively with pulmonary neutrophilia. G-CSF in serum and IL-8 in BALF correlated negatively with PaO(2)/fraction of inspired oxygen (FIO(2)) ratio. However, ENA-78 did not show a correlation with neutrophil count or with PaO(2)/FIO(2) ratio. CONCLUSIONS:G-CSF may be pathophysiologically important for accumulation and activation of neutrophils in ARDS. Local G-CSF production is the likely driving force for neutrophils rather than elevation of circulating levels. In comparison to ENA-78, IL-8 seems to be the predominant neutrophil chemoattractant in the early phase of ARDS.
Authors: Raja-Elie E Abdulnour; Jesmond Dalli; Jennifer K Colby; Nandini Krishnamoorthy; Jack Y Timmons; Sook Hwa Tan; Romain A Colas; Nicos A Petasis; Charles N Serhan; Bruce D Levy Journal: Proc Natl Acad Sci U S A Date: 2014-11-04 Impact factor: 11.205
Authors: Kirsten Neudoerffer Kangelaris; Arun Prakash; Kathleen D Liu; Bradley Aouizerat; Prescott G Woodruff; David J Erle; Angela Rogers; Eric J Seeley; Jeffrey Chu; Tom Liu; Thomas Osterberg-Deiss; Hanjing Zhuo; Michael A Matthay; Carolyn S Calfee Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-03-20 Impact factor: 5.464
Authors: D Clark Files; Chun Liu; Andrea Pereyra; Zhong-Min Wang; Neil R Aggarwal; Franco R D'Alessio; Brian T Garibaldi; Jason R Mock; Benjamin D Singer; Xin Feng; Raghunatha R Yammani; Tan Zhang; Amy L Lee; Sydney Philpott; Stephanie Lussier; Lina Purcell; Jeff Chou; Michael Seeds; Landon S King; Peter E Morris; Osvaldo Delbono Journal: Sci Transl Med Date: 2015-03-11 Impact factor: 17.956
Authors: Catharina F M Linssen; Jan A Jacobs; Foekje F Stelma; Walther N K A van Mook; Peter Terporten; Cornelis Vink; Marjolein Drent; Cathrien A Bruggeman; Annick Smismans Journal: Intensive Care Med Date: 2008-08-05 Impact factor: 17.440
Authors: Lorraine B Ware; Tatsuki Koyama; D Dean Billheimer; William Wu; Gordon R Bernard; B Taylor Thompson; Roy G Brower; Theodore J Standiford; Thomas R Martin; Michael A Matthay Journal: Chest Date: 2009-10-26 Impact factor: 9.410
Authors: Benjamin T Suratt; Mark D Eisner; Carolyn S Calfee; Jenna B Allard; Laurie A Whittaker; Dustin T Engelken; Joseph M Petty; Thomas Trimarchi; Lauren Gauthier; Polly E Parsons Journal: Crit Care Med Date: 2009-04 Impact factor: 7.598
Authors: Guy J Oudhuis; Judith Beuving; Dennis Bergmans; Ellen E Stobberingh; Guul ten Velde; Catharina F Linssen; Annelies Verbon Journal: Intensive Care Med Date: 2009-04-03 Impact factor: 17.440